Insider Transactions in Q2 2022 at Zentalis Pharmaceuticals, Inc. (ZNTL)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 08
2022
|
Enoch Kariuki Director |
BUY
Grant, award, or other acquisition
|
Direct |
21,817
+50.0%
|
-
|
|
Jun 08
2022
|
David Michael Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
24,871
+18.67%
|
-
|
|
May 30
2022
|
Cam Gallagher President, Interim CFO |
BUY
Grant, award, or other acquisition
|
Direct |
111,072
+19.22%
|
-
|
|
Apr 11
2022
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
5,000
-1.19%
|
$155,000
$31.98 P/Share
|
|
Apr 05
2022
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
10,000
-0.69%
|
$510,000
$51.17 P/Share
|
|
Apr 05
2022
|
Anthony Y Sun President & CEO |
SELL
Open market or private sale
|
Direct |
10,471
-0.44%
|
$534,021
$51.73 P/Share
|
|
Apr 04
2022
|
Anthony Y Sun President & CEO |
SELL
Open market or private sale
|
Direct |
10,471
-0.88%
|
$502,608
$48.5 P/Share
|
|
Apr 04
2022
|
Epperly Melissa B, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
17,080
-1.32%
|
$854,000
$50.76 P/Share
|